Congress trades
Bruker Corporation (BRKR)
Free on iOS and Android.
About Bruker Corporation
from the company's filings and listing, as of Oct 20, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Frank H. Laukien
- Employees
- 11,085
- Listed since
- Aug 4, 2000
- Market value
- $8.4B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$0.47
- Dividend yield
- 0.36%
Company news
1 article · newest first| Headline | Source | Date |
|---|---|---|
| Bruker announces preprint on draft atlas of human plasma proteomeThe study used untargeted timsTOF mass spectrometry to map human plasma proteoforms at isoform resolution. | Company release | Oct 6, 2026 |
Written by GetSignal with AI from the company's own SEC filings and press releases; each article links to its source. Not investment advice. Company news from every company we cover
Earnings
6 reported quarters · next on Nov 2, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 4, 2026 | $0.49 | $0.38 | $838.5M | $853.6M | EPS beatRevenue miss |
| Q1 FY2026reported May 6, 2026 | $0.31 | $0.23 | $823.4M | $795.6M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $0.59 | $0.65 | $977.2M | $962.3M | EPS missRevenue beat |
| Q3 FY2025reported Nov 3, 2025 | $0.60 | $0.33 | $860.5M | $964.6M | EPS beatRevenue miss |
| Q2 FY2025reported Aug 4, 2025 | $0.32 | $0.33 | $797.4M | $810.2M | EPS missRevenue miss |
| Q1 FY2025reported May 7, 2025 | $0.47 | $0.46 | $801.4M | $819.9M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 10, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Frank H. Laukien, Ph.D.Chairman, President and Chief Executive Officer | $977K | $1.6M | $2.1M | $4.7M |
| Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO Group | $738K | $792K | $648K | $2.2M |
| Gerald N. HermanExecutive Vice President and Chief Financial Officer | $644K | $866K | $500K | $2.0M |
| Juergen W. SregaPresident, Bruker CALID Group | $504K | $488K | $431K | $1.4M |
| Falko Busse, Ph.D.President, Bruker BioSpin Group | $545K | $311K | $565K | $1.4M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| FMR LLC | $1.2B | 20,237,425 | +25.7% | 13.30% |
| Orbis Allan Gray Ltd | $1.1B | 17,940,076 | 0.0% | 11.79% |
| BlackRock, Inc. | $686.5M | 11,407,332 | +2.0% | 7.50% |
| Pallas Capital Advisors LLC | $570.7M | 9,483,978 | 0.0% | 6.23% |
| Vanguard Portfolio Management LLC | $294.2M | 4,888,290 | +0.7% | 3.21% |
| Vanguard Capital Management LLC | $292.4M | 4,859,252 | +0.9% | 3.19% |
| Sculptor Capital LP | $278.3M | 4,625,000 | +41.4% | 3.04% |
| State Street Corp | $241.9M | 4,017,673 | +2.8% | 2.64% |
| Franklin Templeton Inc | $194.3M | 3,229,337 | +10.6% | 2.12% |
| Sachem Head Capital Management LP | $175.4M | 2,915,000 | New | 1.92% |
| Edmond De Rothschild Holding S.A. | $169.9M | 2,823,178 | -15.9% | 1.85% |
| Dimensional Fund Advisors LP | $157.1M | 2,610,051 | +11.5% | 1.71% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding BRKR
3 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Sculptor Capital | $278.3M | 4,625,000 | 2.3% |
| Steadfast Capital Management | $39.4M | 654,700 | 1.2% |
| Glenview CapitalLarry Robbins | $15.2M | 252,169 | 0.3% |
3 of the 97 fund managers we track list BRKR shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in BRKR
13 disclosures of 13 on record · median 31d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -21.2%After the saleS&P 500 +83.6% · -104.8 pts vs S&P 500 | May 23, 2023 | Jun 12, 2023 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -2.5%S&P 500 +90.4% · -93.0 pts vs S&P 500 | May 10, 2022 | Jun 10, 2022 | 31d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -15.4%After the saleS&P 500 +80.8% · -96.1 pts vs S&P 500 | Jun 2, 2021 | Jul 16, 2021 | 44d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -13.3%After the saleS&P 500 +87.4% · -100.8 pts vs S&P 500 | May 12, 2021 | Jun 17, 2021 | 36d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -16.6%After the saleS&P 500 +83.1% · -99.8 pts vs S&P 500 | May 21, 2021 | Jun 17, 2021 | 27d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -16.8%After the saleS&P 500 +81.4% · -98.1 pts vs S&P 500 | May 26, 2021 | Jun 17, 2021 | 22d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -16.8%After the saleS&P 500 +81.4% · -98.1 pts vs S&P 500 | May 26, 2021 | Jun 17, 2021 | 22d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +7.4%S&P 500 +108.5% · -101.1 pts vs S&P 500 | Dec 14, 2020 | Jan 25, 2021 | 42d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +71.4%S&P 500 +201.8% · -130.5 pts vs S&P 500 | Apr 2, 2020 | May 18, 2020 | 46d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | +71.4%S&P 500 +201.8% · -130.5 pts vs S&P 500 | Apr 2, 2020 | May 18, 2020 | 46d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +57.4%After the saleS&P 500 +167.7% · -110.3 pts vs S&P 500 | Apr 14, 2020 | May 13, 2020 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +50.6%S&P 500 +158.9% · -108.3 pts vs S&P 500 | Apr 29, 2019 | May 10, 2019 | 11d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +111.5%S&P 500 +269.9% · -158.4 pts vs S&P 500 | May 9, 2016 | Jun 16, 2016 | 38d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in BRKR, filterable by party, chamber, type and account.
Members of Congress reporting a position
1 member · estimate, as of Oct 19, 20261 member reports a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Oct 19, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded BRKR?
Ro Khanna and Michael T. McCaul disclosed BRKR transactions in the filings shown here.
Which members of Congress hold BRKR?
1 member of Congress reports a position in BRKR in the estimate we hold as of Oct 19, 2026. The estimated position belongs to Lucy McBath. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are BRKR trades disclosed?
Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.